<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Tolnaftate: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Tolnaftate: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Tolnaftate: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="10005" href="/d/html/10005.html" rel="external">see "Tolnaftate: Drug information"</a> and <a class="drug drug_patient" data-topicid="11104" href="/d/html/11104.html" rel="external">see "Tolnaftate: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F229126"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Anti-Fungal [OTC] [DSC];</li>
<li>Antifungal (Tolnaftate) [OTC];</li>
<li>Dr Gs Clear Nail [OTC];</li>
<li>Formula 3 The Treatment [OTC];</li>
<li>Formula 7 The Solution [OTC];</li>
<li>FT Antifungal [OTC];</li>
<li>Fungi-Guard [OTC];</li>
<li>Fungoid-D [OTC] [DSC];</li>
<li>LamISIL AF Defense [OTC] [DSC];</li>
<li>Micomitin [OTC];</li>
<li>Micotrin AL [OTC];</li>
<li>Mycocide Clinical NS [OTC];</li>
<li>Mycozyl AL;</li>
<li>Mycozyl AL [OTC];</li>
<li>Tinactin Deodorant [OTC];</li>
<li>Tinactin [OTC];</li>
<li>Tinaspore [OTC];</li>
<li>TM-Tolnaftate LR [OTC];</li>
<li>TM-Tolnaftate [OTC];</li>
<li>Tolnafi-AL [OTC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1050377"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antifungal Agent, Topical</span></li></ul></div>
<div class="block dop drugH1Div" id="F229142"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="b1376e31-faad-4461-817a-14499006c2ba">Tinea pedis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea pedis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Treatment: </i>Children ≥2 years and Adolescents: Topical: Apply twice daily for 4 weeks</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Prevention: </i>Children ≥2 years and Adolescents: Topical: Apply once or twice daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cbf1eec8-9d01-4057-9021-3b2606e23768">Tinea corporis, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea corporis, treatment: </b>Children ≥2 years and Adolescents: Topical: Apply twice daily for 4 weeks.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8acc9cf6-50d2-4cf0-ba51-6afb4c9b60b8">Tinea cruris, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea cruris, treatment:</b> Children ≥2 years and Adolescents: Topical: Apply twice daily for 2 weeks.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51196272"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block dohp drugH1Div" id="F51196273"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doa drugH1Div" id="F229129"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="10005" href="/d/html/10005.html" rel="external">see "Tolnaftate: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="15c0a5bc-b04b-4bce-808a-eba28afcd673">Tinea infections</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Tinea infections:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Tinea corporis/tinea cruris:</i>
<b>Topical:</b> Apply to affected and surrounding area(s) twice daily until clinical resolution, typically 1 to 4 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12046779','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12046779','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Tinea pedis (labeled use)/tinea manuum (off-label use):</i></p>
<p style="text-indent:-2em;margin-left:6em;">Treatment: <b>Topical:</b> Apply to affected and surrounding area(s) twice daily until 1 week after clinical resolution, typically for 4 weeks total (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12046779','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12046779','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Prevention (tinea pedis only): <b>Topical:</b> Apply once or twice daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991932"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block doha drugH1Div" id="F50989188"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.</p></div>
<div class="block adr drugH1Div" id="F229113"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Contact dermatitis, pruritus, stinging of the skin</p>
<p style="text-indent:-2em;margin-left:2em;">Local: Irritation</p></div>
<div class="block coi drugH1Div" id="F57868157"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">OTC labeling: When used for self-medication, do not use on children &lt;2 years of age.</p></div>
<div class="block war drugH1Div" id="F229110"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Irritation: Discontinue if sensitivity or irritation occurs.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): When used for self-medication (OTC use), contact health care provider if condition does not improve within 4 weeks. Avoid contact with eyes. Not effective on the scalp.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878654"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F229118"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Aerosol, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tinactin: 1% (150 g [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Aerosol Powder, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">LamISIL AF Defense: 1% (133 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tinactin: 1% (133 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tinactin Deodorant: 1% (133 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Antifungal (Tolnaftate): 1% (14.18 g) [odorless]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Antifungal: 1% (15 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Fungi-Guard: 1% (15 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Fungoid-D: 1% (113 g [DSC]) [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tinactin: 1% (15 g, 30 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (14 g, 14.18 g, 15 g, 20 g, 28 g, 28.3 g, 30 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Powder, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Anti-Fungal: 1% (45 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (45 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dr Gs Clear Nail: 1% (18 mL) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Formula 3 The Treatment: 1% (15 mL) [contains butylparaben, methylparaben, propylparaben, sesame oil]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Formula 7 The Solution: 1% (15 g) [contains disodium edta]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micomitin: 1% (30 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micotrin AL: 1% (30 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mycocide Clinical NS: 1% (30 mL) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mycozyl AL: 1% (10 mL, 30 mL) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tinaspore: 1% (10 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">TM-Tolnaftate: 1% (30 mL, 45 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">TM-Tolnaftate LR: 1% (45 mL) [contains cetearyl alcohol, isopropyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Tolnafi-AL: 1% (30 mL)</p></div>
<div class="block geq drugH1Div" id="F229106"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F16324003"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Tinactin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.42</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Tolnaftate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.15 - $0.29</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Powder</b> (Tolnaftate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.06 - $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Formula 3 The Treatment External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $1.08</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Formula 7 The Solution External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $1.36</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Micomitin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $56.50</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Micotrin AL External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $75.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Mycozyl AL External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $110.00</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52613945"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For external use only; avoid contact with eyes. Wash and dry affected area before drug application. For tinea pedis, also apply to spaces between the toes.</p>
<p style="text-indent:-2em;margin-left:2em;">Aerosol, aerosol powder, solution: Shake well prior to use.</p></div>
<div class="block adm drugH1Div" id="F50709429"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b> For external use only; avoid contact with eyes. Wash and dry affected area before drug application. Ensure coverage of nail edges, cuticles, and skin around the nails. For tinea pedis, also apply to spaces between the toes.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Aerosol, aerosol powder:</b> Shake well prior to use.</p></div>
<div class="block sts drugH1Div" id="F57868158"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Aerosol, aerosol powder, cream, liquid, powder: Store at 20°C to 25°C (68°F to 77°F). Store away from excessive heat, direct light, and cold. Do not puncture, break, or burn the aerosol powder or aerosol solution container. Do not store at temperatures above 48.9°C (120°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Solution: Store at 15°C to 30°C (59°F to 86°F). Store away from excessive heat, direct light, and cold. The solution solidifies at low temperatures and liquifies readily when warmed, retaining its potency. Protect from freezing.</p></div>
<div class="block usep drugH1Div" id="F53569209"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of tinea pedis, tinea cruris, and tinea corporis (OTC products: FDA approved in ages ≥2 years and adults). <b>Note:</b> Topical therapy is not effective for infection of the scalp or nails. Indications vary by product; consult product-specific labeling for indications.</p></div>
<div class="block mst drugH1Div" id="F229161"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Tinactin may be confused with Talacen</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300155"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F229114"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block mopp drugH1Div" id="F53569210"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Resolution of skin infection</p></div>
<div class="block pha drugH1Div" id="F229109"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Distorts the hyphae and stunts mycelial growth in susceptible fungi</p></div>
<div class="block phk drugH1Div" id="F229121"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Onset of action: 24 to 72 hours</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F229123"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Tinea Cure</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Scholls tinea | Tinaderm | Tineafax</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Tinactin | Tinaderm</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Sorgoa | Tinatox | Tolnaftat | Tonoftal</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Hongo killer | Secalia | Tinaderm | Ting | Tolnaftin</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm | Zinoderm</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Tineacure</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Micoisdin | Tinaderm</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Sporiline</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Mycil | Mycil athlete's foot | Scholl Advance Athlete's Foot | Scholl athlet foot | Tinaderm | Tinaderm plus</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Aftate</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Athlete'S Foot | Chinofungin | Disifungin</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Mycil | Tinaderm | Tinaderm plus</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Athlete'S Foot | Pitrex</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm | Tolnaderm sterkem</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Fungal Nail</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Sorgoa</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Antifungal | Scholl athlete's foot</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Excelsior mic | Tinaderm | Tinoxal</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Creobic | Myco-Aid | Scholl athlete's foot | Tinaderm | Tinalite | Tolnaderm</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Savlon footcare | Tinaderm</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Tinactin | Tolnaderm</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Breezee | Lamisil AF Defense | Q-Naftate | Tinactin | Tinactin Chill | Tinactin Foot &amp; Sneaker Deodorant | Tineacide | Ting</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Tinaderme</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Tinea Cure</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Hi vetic | Scholl athlete's foot | Tinaderm | Tolnaderm</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Fugicid | Misone | Tolnaderm | Tonaf</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Tinactin</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Naff | Tollfe | Tolnaf</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm | Tolnaftan</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Tinaderm</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/tolnaftate-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Goldstein.1">
<a name="Goldstein.1"></a>Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 24, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Micotrin.1">
<a name="Micotrin.1"></a>Micotrin AL (tolnaftate spray) [prescribing information]. Panorama City, CA: Pure Tek Corporation LLC; October 2021.</div>
</li>
<li>
<div class="reference">
                  Proclearz Max Strength Fungal Shield Brush-On Antifungal (tolnaftate solution liquid) [prescribing information]. Brooklyn, NY: PROFOOT, Inc.; March 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med. 2009;10(2):256-259.</i>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/tolnaftate-pediatric-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Tinactin Jock Itch (tolnaftate powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.</div>
</li>
<li>
<div class="reference">
                  Tinactin (tolnaftate deodorant powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.</div>
</li>
<li>
<div class="reference">
                  Tinactin (tolnaftate powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC; received October 2019.</div>
</li>
<li>
<div class="reference">
                  Tinactin (tolnaftate spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.</div>
</li>
<li>
<div class="reference">
                  Tolnaftate 1% topical solution [prescribing information]. Allegan, MI: Perrigo Pharmaceuticals.</div>
</li>
<li>
<div class="reference">
                  Tolnaftate cream USP 1% [prescribing information]. Allegan, MI: Perrigo Pharmaceuticals.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12046779">
<a name="12046779"></a>Weinstein A, Berman B. Topical treatment of common superficial tinea infections. <i>Am Fam Physician</i>. 2002;65(10):2095-2102.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/tolnaftate-pediatric-drug-information/abstract-text/12046779/pubmed" id="12046779" target="_blank">12046779</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12849 Version 286.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
